Novavax COVID-19 vaccine produces immunity
Second dose of treatment generates response among young people during Oxford University trial
Read More
Tag: Novavax
Novavax joins Oxford mix-and-match COVID-19 vaccine study in adolescents
The Phase II clinical trial will include at least 360 adolescents aged 12-16 years old
Read More
Novavax begins COVID-19, flu combination vaccine trial
The trial will aim to enrol 640 healthy adults, aged 50- to 70-years-old
Read More
Study demonstrates safety and efficacy of co-administering COVID-19 and flu vaccines
Study co-administered Novavax’s COVID-19 vaccine alongside Seqirus’ flu vaccines
Read More
Novavax’s COVID-19 vaccine shows 90% efficacy in Phase III
Jab was also found to be 100% effective at preventing moderate to severe COVID-19
Read More
UK trial evaluating ‘mix and match’ COVID-19 vaccine regimens expanded
Trial will now include vaccines developed by Moderna and Novavax
Read More
GSK agrees to support manufacture of Novavax’ COVID-19 vaccine
British drugmaker will help to produce up to 60 million doses for use in the UK
Read More
Novavax’s COVID-19 vaccine ‘highly’ effective against UK variant
Vaccine found to have an overall vaccine efficacy of 89.7% in Phase III trial
Read More
Multiple rolling reviews kick-off for Novavax’s COVID-19 vaccine
Jab recently demonstrated 89.3% efficacy in UK trial
Read More
Novavax COVID-19 vaccine found to be 89.3% effective in UK trial
Meanwhile, Phase IIb results from South Africa trial demonstrated 60% efficacy
Read More
Novavax begins phase III coronavirus vaccine trial in the UK
Trial is being conducted in partnership with UK government’s Vaccines Taskforce
Read More
UK inks further coronavirus vaccine deals
Deals agreed with Janssen and Novavax for another 90 million doses
Read More
- US study reveals interferon combinations cause lupus symptoms and affect treatment
- NIHR and TJBCM announce new funding initiative for novel brain tumour research
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
